Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Breast Neoplasms 2 Pancreatic Neoplasms 1 Heart Failure 1 Cardiotoxicity 1 Atherosclerosis 1

Interventions

Gemcitabine 78 Fluorouracil 27 Oxaliplatin 24 130-nm albumin-bound paclitaxel 24 Leucovorin 18 Capecitabine 15 Albumin-Bound Paclitaxel 15 S 1 (combination) 14 Taxes 12 Irinotecan 11 pembrolizumab 9 folfirinox 9 Radiosurgery 9 Radiotherapy 7 Drug Therapy 7 Cisplatin 7 irinotecan sucrosofate 6 Pancreaticoduodenectomy 5 Paclitaxel 5 Injections 5 Docetaxel 5 Blood Specimen Collection 5 apatinib 4 Radiofrequency Ablation 4 Radiation 4 Biopsy 4 tislelizumab 3 rubitecan 3 nimotuzumab 3 camrelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Hydroxymethylglutaryl-CoA Reductase Inhibitors × Clear all

NCT04245644 2024-03-12

CAOS

IRCCS San Raffaele

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡